A research group at the University of North Carolina-Chapel Hill recently presented their technology for delivering anticancer [MORE]
Using a hand-held six light device, researchers at the Machine Vision Laboratory (Bristol Institute of Technology, Bristol, UK) are [MORE]
Protein scientists in Germany and Japan have developed a new biochip that can detect proteins for specific diseases and [MORE]
The tumor suppressor gene p53 is implicated in most forms of cancer, though the gene itself does not have [MORE]
Cancer researchers and physicians are awaiting clinical outcome data that Mark Davis and colleagues will present at the June [MORE]
Dr. Gerd Binning
Royal Philips Electonics, in the Netherlands, and Munich-based Definiens have signed an agreement to pursue molecular imaging. [MORE]
Using a microfluidic chip that researchers at Harvard developed three years ago to capture metastatic prostate cells in the [MORE]
A recent study reported on the importance of DNA copy number variations-both duplications and deletions on chromosomes-in causing cancers. Indeed, [MORE]
Dutch diagnostic company Qiagen will be holding a one day seminar, June 9, 2010, on recent technical advances in [MORE]
As an indication of things to come, Qiagen (Venlo, The Netherlands) signed an exclusive agreement with Johns Hopkins [MORE]
Residual cancer, after surgery, leaves biomakers in the blood-both protein and DNA. Protein markers tend to be less specific [MORE]
It’s not surprising that in searching for genomic individuality, researchers would find pathway-exhibiting cohorts based on age and gender. Still, [MORE]
“Cellvizio” is the name of a small microscope that can be inserted into the colon or pancreatic bile duct [MORE]
Swiss diagnostic and therapeutic giant, Roche, recently invested more than $181m in Halozyme Therapeutics (San Diego, CA) to develop a [MORE]
Recently, The Pharmacogenomics Journal published a study that John Deeken, at Georgetown University’s Lombardi Cancer Center, carried out [MORE]
Professor Huikai Xie, director of the Biophotonics and Microsystems Laboratory at the University of Florida, has developed an endoscope [MORE]
Gastrocor, Inc. (Glen Allen, VA) has developed the first tissue-based fluorescence in situ hybridization (FISH) diagnostic test for chromosome abnormalities [MORE]
German physician Andreas Gruentzig invented balloon angioplasty in 1977, but University of Texas physician and bioengineer John Simpson developed the [MORE]
Provista Life Sciences (Phoenix, AZ) is now marketing in 41 states a “Biomarker Translation Test” or “BT Test” for breast [MORE]
Broncus Technologies (Mountain View, CA) has installed its first “LungPoint” system at the John Lincoln Hospital in Phoenix. It is [MORE]